Yu Wen

1.6k total citations
57 papers, 1.2k citations indexed

About

Yu Wen is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, Yu Wen has authored 57 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Pulmonary and Respiratory Medicine, 17 papers in Surgery and 14 papers in Oncology. Recurrent topics in Yu Wen's work include Nanoplatforms for cancer theranostics (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers). Yu Wen is often cited by papers focused on Nanoplatforms for cancer theranostics (12 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (10 papers). Yu Wen collaborates with scholars based in China, United States and Canada. Yu Wen's co-authors include Li Xiong, Xiongying Miao, Heng Zou, Zijian Zhang, Zhulin Yang, Jiangjiao Zhou, Qinglong Li, Kunpeng Wang, Zhongtao Liu and Wei Chen and has published in prestigious journals such as Scientific Reports, Coordination Chemistry Reviews and Medicine.

In The Last Decade

Yu Wen

55 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yu Wen China 22 332 322 317 311 275 57 1.2k
Xiaomeng Dai China 24 433 1.3× 389 1.2× 826 2.6× 105 0.3× 644 2.3× 54 1.9k
Di Lu China 22 166 0.5× 213 0.7× 869 2.7× 342 1.1× 572 2.1× 88 2.2k
Ri‐Sheng Yu China 18 296 0.9× 246 0.8× 213 0.7× 105 0.3× 237 0.9× 94 1.2k
Hong Shan China 20 179 0.5× 138 0.4× 232 0.7× 360 1.2× 114 0.4× 70 1.2k
Sen Guo China 18 183 0.6× 114 0.4× 907 2.9× 235 0.8× 288 1.0× 37 1.7k
Haozhen Ren China 26 448 1.3× 124 0.4× 910 2.9× 314 1.0× 215 0.8× 86 2.2k
Wentao Kong China 17 219 0.7× 186 0.6× 79 0.2× 123 0.4× 107 0.4× 68 837
Yusheng Cheng China 16 129 0.4× 189 0.6× 384 1.2× 89 0.3× 384 1.4× 50 1.3k
Hongxue Meng China 20 273 0.8× 262 0.8× 479 1.5× 109 0.4× 321 1.2× 102 1.4k

Countries citing papers authored by Yu Wen

Since Specialization
Citations

This map shows the geographic impact of Yu Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yu Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yu Wen more than expected).

Fields of papers citing papers by Yu Wen

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yu Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yu Wen. The network helps show where Yu Wen may publish in the future.

Co-authorship network of co-authors of Yu Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Yu Wen. A scholar is included among the top collaborators of Yu Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yu Wen. Yu Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Zhang, Zhiwei, Qian Li, Hao Li, et al.. (2024). Integrative multi-omics analysis reveals the contribution of neoVTX genes to venom diversity of Synanceia verrucosa. BMC Genomics. 25(1). 1210–1210. 1 indexed citations
3.
Wang, Yongxiang, Hui Zhou, Zijian Zhang, et al.. (2024). Surufatinib combined with photodynamic therapy induces ferroptosis to inhibit cholangiocarcinoma in vitro and in tumor models. Frontiers in Pharmacology. 15. 1288255–1288255. 11 indexed citations
5.
Li, Dapeng, Yanxun Han, Yisheng He, et al.. (2023). A global assessment of incidence trends of autoimmune diseases from 1990 to 2019 and predicted changes to 2040. Autoimmunity Reviews. 22(10). 103407–103407. 34 indexed citations
6.
Xie, Wei, et al.. (2023). Robust wave compensation controller design for an active hexapod platform with time-varying input delays. Ocean Engineering. 274. 114084–114084. 11 indexed citations
7.
Li, Xiaoyu, et al.. (2023). Photodynamic Therapy Combined with Ferroptosis Is a Synergistic Antitumor Therapy Strategy. Cancers. 15(20). 5043–5043. 25 indexed citations
8.
Zhang, Zijian, Kunpeng Wang, Hao Jiang, et al.. (2022). Comprehensive Analysis of the Potential Immune-Related Biomarker ATG101 that Regulates Apoptosis of Cholangiocarcinoma Cells After Photodynamic Therapy. Frontiers in Pharmacology. 13. 857774–857774. 1 indexed citations
9.
Zhou, Hui, Zhongtao Liu, Zijian Zhang, et al.. (2022). Copper-cysteamine nanoparticle-mediated microwave dynamic therapy improves cancer treatment with induction of ferroptosis. Bioactive Materials. 24. 322–330. 54 indexed citations
10.
Zhou, Jiangjiao, Wen‐Hao Chen, Heng Zou, et al.. (2020). Rare postoperative hemorrhage after robotic-assisted pancreatoduodenectomy for pancreatic head cancer: a case report. Journal of Gastrointestinal Oncology. 11(4). 820–825. 2 indexed citations
11.
Zhou, Jiangjiao, Li Xiong, Xiongying Miao, et al.. (2020). Outcome of robot-assisted pancreaticoduodenectomy during initial learning curve versus laparotomy. Scientific Reports. 10(1). 9621–9621. 12 indexed citations
12.
Chen, Xiang, Bin Yi, Zhongtao Liu, et al.. (2020). Global, regional and national burden of pancreatic cancer, 1990 to 2017: Results from the Global Burden of Disease Study 2017. Pancreatology. 20(3). 462–469. 28 indexed citations
13.
Zhang, Zequn, Heng Zou, Li Xiong, et al.. (2019). ALBI/ST ratio versus FIB-4 and APRI as a predictor of posthepatectomy liver failure in hepatocellular carcinoma patients. Medicine. 98(15). e15168–e15168. 10 indexed citations
14.
Wang, Yu-tong, et al.. (2018). Changes of mechanoreceptors in different-state remnants of ruptured anterior cruciate ligament. International Orthopaedics. 42(11). 2613–2618. 10 indexed citations
15.
Yao, Hongliang, Yu Wen, Hua Zhao, et al.. (2018). Functional role of a long non-coding RNA LIFR-AS1/miR-29a/TNFAIP3 axis in colorectal cancer resistance to pohotodynamic therapy. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 1864(9). 2871–2880. 59 indexed citations
16.
Chen, Bo, Yanan Cui, Lin Zhou, et al.. (2018). Ready player one? Autophagy shapes resistance to photodynamic therapy in cancers. APOPTOSIS. 23(11-12). 587–606. 31 indexed citations
17.
Chen, Xiang, Heng Zou, Li Xiong, et al.. (2017). Predictive power of splenic thickness for post-hepatectomy liver failure in HBV-associated hepatocellular carcinoma patients. World Journal of Surgical Oncology. 15(1). 216–216. 9 indexed citations
18.
Xiong, Li, et al.. (2014). In vivo and in vitro evaluation of the cytotoxic effects of Photosan-loaded hollow silica nanoparticles on liver cancer. Nanoscale Research Letters. 9(1). 319–319. 16 indexed citations
19.
Xiong, Li, Yu Wen, Xiongying Miao, & Zhulin Yang. (2013). NT5E and FcGBP as key regulators of TGF-1-induced epithelial–mesenchymal transition (EMT) are associated with tumor progression and survival of patients with gallbladder cancer. Cell and Tissue Research. 355(2). 365–374. 113 indexed citations
20.
Wen, Yu. (2011). Changes of the proprioceptors in the partly injuried knee joint ACL of rabbits. Shandong yiyao. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026